ferrocifen

04/15/2022 - "Diversity-oriented synthesis and bioactivity evaluation of N-substituted ferrocifen compounds as novel antiproliferative agents against TNBC cancer cells."
05/11/2021 - "This review provides an exhaustive summary of the use of ferrocifen-loaded LNCs as a promising nanomedicine, outlining the ferrocifen mechanisms of action on cancer cells, the nanocarrier formulation process and the in vivo results obtained over the last two decades."
03/15/2020 - "Currently, Ferrocifen is in pre-clinical trial against cancers. "
07/24/2018 - "Antiproliferative activities of several members of the ferrocifen family, both in vitro and in vivo, are well documented although their precise location in cancer cells has not yet been elucidated. "
12/21/2015 - "Ferrocifen type anti cancer drugs."

01/25/2021 - "The ferrocifen family represents promising bioorganometallic molecules for melanoma treatment since they show potent anticancer properties. "
02/01/2021 - "Corrigendum to "p722 ferrocifen loaded lipid nanocapsules improve survival of murine xenografted-melanoma via a potentiation of apoptosis and an activation of CD8+ T lymphocytes" [Int. "
01/25/2021 - "p722 ferrocifen loaded lipid nanocapsules improve survival of murine xenografted-melanoma via a potentiation of apoptosis and an activation of CD8+ T lymphocytes."
11/01/2008 - "Here we describe the properties of two organometallic ferrocenyl derivatives, ferrocifen (Fc-OH-Tam) and ferrociphenol (Fc-diOH) that show a specific antiproliferative effect on melanoma cells. "
05/11/2021 - "The different in vitro and in vivo experiments performed with this ferrocifen-loaded nanocarrier have revealed promising results in several multidrug-resistant cancer cell lines such as glioblastoma, breast cancer and metastatic melanoma, alone or in combination with other therapies. "

06/01/2014 - "Ferrocifens are an original class of ferrocifen-type breast cancer drugs. "
01/01/2008 - "Hydroxyferrocifen compounds are a new and promising class of ferrocifen-type breast-cancer drug candidates. "
06/01/2014 - "In this work, fluorescence measurements indicated the production of reactive oxygen species (ROS) if hormone-dependent or -independent breast cancer cells were incubated with three hit ferrocifen compounds. "
12/23/2005 - "Ferrocene-mediated proton-coupled electron transfer in a series of ferrocifen-type breast-cancer drug candidates."
05/11/2021 - "The different in vitro and in vivo experiments performed with this ferrocifen-loaded nanocarrier have revealed promising results in several multidrug-resistant cancer cell lines such as glioblastoma, breast cancer and metastatic melanoma, alone or in combination with other therapies. "

01/01/2023 - "Promising perspectives to use these ferrocifen-loaded LNCs to treat glioblastoma could be readily envisaged by local application of the gel in the cavity after tumor resection."
05/11/2021 - "The different in vitro and in vivo experiments performed with this ferrocifen-loaded nanocarrier have revealed promising results in several multidrug-resistant cancer cell lines such as glioblastoma, breast cancer and metastatic melanoma, alone or in combination with other therapies. "
01/01/2023 - "In recent decades, ferrocifen lipid nanocapsules (LNCs) have been successfully formulated and have demonstrated anticancer activity on multidrug-resistant cancers in several mice and rat models (glioblastoma, breast cancer, and metastatic melanoma). "

11/21/2013 - "Efficient new constructs against triple negative breast cancer cells: synthesis and preliminary biological study of ferrocifen-SAHA hybrids and related species."